|
||
T e a c h i n g | ||
Dr. Yule began teaching at UBC in the Department of Anatomy as a teaching assistant in histology while completing her MSc. After many years of research in the field of breast cancer, she focused her career on education and began instructing anatomy and physiology to undergraduate students at the University College of the Fraser Valley in Abbotsford. With the expansion of the MD Undergraduate Program, Dr. Yule came back to UBC in September 2007. She is now involved in the first and second year curriculum teaching histology and gross anatomy and tutoring problem-based learning to medical and dental students. She also gives lectures on microscopic anatomy to undergraduate students in Anatomy 390. In the summer, Dr. Yule supervises MD Undergraduate student projects and researches in the field of medical education. | ||
P u b l i c a t i o n s ( n é e A n d r e w s ) | ||
Kerr, L.R., Andrews, H.N., Strange, K.S., Emerman, J.T., & Weinberg, J. Temporal factors alter effects of social housing conditions on responses to chemotherapy and hormone levels in a Shionogi mammary tumor model. Psychosomatic Medicine 68 (6): 966-75, 2006. Andrews, H.N., Habibi, G., Kucab, J.E., & Dunn, S.E. Celecoxib inhibits urokinase-type plasminogen activator (uPA) in MDA-MB-231 breast cancer cells. Breast Cancer Research and Treatment 94 (1): 47-52, 2005. Nielson, T.O., Andrews, H.N., Cheang, M., Kucab, J.E., Hsu, F.D., Ragaz, J., Gilks, C.B., Makretsov, N., Bajdik, C.D., Brookes, C., Neckers, L.M., Evdokimova, V., Huntsman, D.G., & Dunn, S.E. Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin. Cancer Research 64 (1): 286-94, 2004. Gilmore, P.M., McCabe, N., Quinn, J.E., Kennedy, R.D., Gorski, J.J., Andrews, H.N., McWilliams, S., Carty, M., Mullan, P.B., Duprex, W.P., Liu, E.T., Johnston, P.G., & Harkin, D.P. BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3. Cancer Research 15; 64 (12):4148-54, 2004. Andrews, H.N., Mullan, P.B., McWilliams, S., Sebelova, S., Quinn, J.E., Gilmore, P.M., McCabe, N., Pace, A., Koller, B., Johnston, P.G., Haber, D.A, & Harkin, D.P. BRCA1 regulates the interferon gamma-mediated apoptotic response. Journal of Biological Chemistry 19; 277 (29): 26225-32, 2002. Mullan, P.B., Quinn, J., Gilmore, P., McWilliams, S., Andrews, H.N., Gervin, C., McCabe, N., McKenna, S.,White, P., Song, Y.H, Mahsewaran, S., Liu, E., Haber, D.A., Johnston, P.G., & Harkin, D.P. BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents. Oncogene 20 (43): 6123-31, 2001. Andrews, H.N., Kerr, L.R., Strange, K.S., Emerman, J.T., & Weinberg, J. Effects of social housing condition on stress protein expression in the Shionogi mouse mammary carcinoma (SC115). Breast Cancer Research and Treatment 59 (3): 1999-209, 2000. For further information, please click here. |
||
C o n f e r e n c e P r e s e n t a t i o n s | ||
|